CARE Ratings Limited carries a market capitalization of 48.76B, placing it among publicly traded companies globally. Its enterprise value stands at 37.61B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 48.76B |
| Enterprise Value | 37.61B |
CARE Ratings Limited currently has 30.05M shares outstanding.
| Shares Outstanding | 30.05M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
CARE Ratings Limited trades at a trailing price-to-earnings ratio of 25.38. The price-to-sales ratio is 9.18, and the price-to-book ratio stands at 144.61.
| PE Ratio | 25.38 |
| PS Ratio | 9.18 |
| PB Ratio | 144.61 |
| P/TBV Ratio | 4.72 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, CARE Ratings Limited trades at an EV/EBITDA multiple of 20.57 and an EV/FCF ratio of 2,049.61. The EV/Sales ratio of 7.95 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 20.57 provides insight into valuation relative to core operating earnings.
| EV / Sales | 7.95 |
| EV / EBITDA | 20.57 |
| EV / EBIT | 20.57 |
| EV / FCF | 2,049.61 |
CARE Ratings Limited maintains a current ratio of 5.76, meaning it holds 5.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 2.78, indicating elevated leverage, while an interest coverage ratio of 73.55 demonstrates strong ability to service its debt obligations.
| Current Ratio | 5.76 |
| Quick Ratio | 5.28 |
| Debt / Equity | 2.78 |
| Debt / EBITDA | 0.14 |
| Interest Coverage | 73.55 |
CARE Ratings Limited posts a return on equity of 67.74 and a return on invested capital of 14.90.
| Return on Equity (ROE) | 67.74 |
| Return on Assets (ROA) | 16.60 |
| Return on Invested Capital (ROIC) | 14.90 |
| Return on Capital Employed (ROCE) | 59.27 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Over the trailing twelve months, CARE Ratings Limited has paid 616.58M in income taxes, reflecting an effective tax rate of 26.20.
| Income Tax | 616.58M |
| Effective Tax Rate | 26.20 |
CARE Ratings Limited's stock has declined approximately -9.39245% over the past 52 weeks. The 50-day moving average sits at 1,613.05, while the 200-day moving average is 1,587.59.
| Beta (5Y) | N/A |
| 52-Week Price Change | -9.39245% |
| 50-Day Moving Average | 1,613.05 |
| 200-Day Moving Average | 1,587.59 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, CARE Ratings Limited generated 4.73B in revenue and converted that into 1.71B in net income, yielding earnings per share of 57.63. EBITDA reached 1.83B, while operating income came in at 1.83B.
| Revenue | 4.73B |
| Gross Profit | 2.59B |
| Operating Income | 1.83B |
| Pretax Income | 2.35B |
| Net Income | 1.71B |
| EBITDA | 1.83B |
| EBIT | 1.83B |
| Earnings Per Share (EPS) | 57.63 |
CARE Ratings Limited holds 6.21B in cash and equivalents against 261.84M in total debt, resulting in a net debt position of -425.99M. Total book value stands at 300.47M, with working capital of 5.60B providing operational flexibility.
| Cash & Cash Equivalents | 6.21B |
| Total Debt | 261.84M |
| Net Debt | -425.99M |
| Equity (Book Value) | 300.47M |
| Book Value Per Share | 10.02 |
| Working Capital | 5.60B |
CARE Ratings Limited operates with a gross margin of 54.78, reflecting its pricing power and cost economics. The operating margin of 38.66 and net profit margin of 36.18 provide insight into operational efficiency.
| Gross Margin | 54.78 |
| Operating Margin | 38.66 |
| Pretax Margin | 49.75 |
| Profit Margin | 36.18 |
| EBITDA Margin | 38.66 |
CARE Ratings Limited posts an Altman Z-Score of 17.75, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 17.75 |